194 related articles for article (PubMed ID: 4604153)
21. Drug doses for children. A rational approach to an old problem.
Habersang R; Kauffman RE
J Kans Med Soc; 1974 Mar; 75(3):98-103. PubMed ID: 4593019
[No Abstract] [Full Text] [Related]
22. Biologic availability and therapeutic equivalence.
Arnold JD; Sicé J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):546-9. PubMed ID: 977793
[No Abstract] [Full Text] [Related]
23. Non-equivalence of digoxin tablets.
Reissell P; Manninen V; Ojala K; Karjalainen J
Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
[No Abstract] [Full Text] [Related]
24. Bioavailability of digoxin in man after oral administration of preparations with different dissolution rate.
Nyberg L
Acta Pharmacol Toxicol (Copenh); 1977; 40 Suppl 3():1-48. PubMed ID: 301340
[No Abstract] [Full Text] [Related]
25. [Biologic availability of drugs in humans and animals].
Wichliński L
Pol Tyg Lek; 1975 Dec; 30(50):2111-2. PubMed ID: 1197106
[No Abstract] [Full Text] [Related]
26. [Bioavailability and its significance in pharmacotherapy].
Wiela-Hojeńska A; Orzechowska-Juzwenko K
Pol Merkur Lekarski; 2003 Jan; 14(79):89-93. PubMed ID: 12712840
[TBL] [Abstract][Full Text] [Related]
27. Strategies to improve oral drug bioavailability.
Gomez-Orellana I
Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
[TBL] [Abstract][Full Text] [Related]
28. [The consequence of the preparation factors for the effect of the drug].
Johnsgård M; Pedersen AO
Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086
[No Abstract] [Full Text] [Related]
29. [Drug dosage form and action].
Zathurecký L
Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397
[No Abstract] [Full Text] [Related]
30. Proceedings: Bioavailability and therapeutic efficacy.
Withey RJ
Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
[No Abstract] [Full Text] [Related]
31. [Metabolism and pharmacokinetics of lanatosides in man].
Rietbrock N; Abshagen U
Dtsch Med Wochenschr; 1973 Jan; 98(3):117-22. PubMed ID: 4684137
[No Abstract] [Full Text] [Related]
32. Rate-controlled drug delivery.
Goldman P
N Engl J Med; 1982 Jul; 307(5):286-90. PubMed ID: 7045668
[No Abstract] [Full Text] [Related]
33. Clinical pharmacokinetics (second of two parts).
Greenblatt DJ; Koch-Weser J
N Engl J Med; 1975 Nov; 293(19):964-70. PubMed ID: 1101062
[No Abstract] [Full Text] [Related]
34. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
Corrigan OI; Timoney RF
Ir J Med Sci; 1974 Jul; 143(4):197-207. PubMed ID: 4605123
[No Abstract] [Full Text] [Related]
35. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.
Garrett ER
Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331
[No Abstract] [Full Text] [Related]
36. Some factors affecting bioavailability of drug products.
Lach JL
J Iowa Med Soc; 1972 Aug; 62(8):441-2 passim. PubMed ID: 5044776
[No Abstract] [Full Text] [Related]
37. Prediction of systemic availability from plasma-level data after oral drug administration.
Perrier D; Gibaldi M; Boyes RN
J Pharm Pharmacol; 1973 Mar; 25(3):256-7. PubMed ID: 4146327
[No Abstract] [Full Text] [Related]
38. Drug therapy. Binding of drugs to serum albumin (second of two parts).
Koch-Weser J; Sellers EM
N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
[No Abstract] [Full Text] [Related]
39. Bioavailability of digoxin: what the clinician needs to know.
Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
Conn Med; 1974 May; 38(5):230-2. PubMed ID: 4831099
[No Abstract] [Full Text] [Related]
40. Dosage, compliance and bioavailability in perspective.
Biron P
Can Med Assoc J; 1976 Jul; 115(2):102-3. PubMed ID: 1277066
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
